STOCK TITAN

Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Prenetics (NASDAQ: PRE) will release third quarter 2025 financial results for the period ended September 30, 2025 before market open on Monday, November 10, 2025. The company will hold its inaugural earnings conference call the same day at 8:30 a.m. Eastern Time to discuss results and answer analyst questions.

Dial-in details: 1-844-425-9470 (U.S.) and 201-298-0878 (international). A live webcast will be available on the PRE conference call page and an audio replay will be posted on the investor relations website at https://ir.prenetics.com/.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 7 Alerts

-5.64% News Effect
-$14M Valuation Impact
$234M Market Cap
0.1x Rel. Volume

On the day this news was published, PRE declined 5.64%, reflecting a notable negative market reaction. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $14M from the company's valuation, bringing the market cap to $234M at that time.

Data tracked by StockTitan Argus on the day of publication.

CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced it will release financial results for the third quarter 2025 ended September 30, 2025 before market open on Monday, November 10, 2025. The Company will also hold its first ever earnings conference call the same day at 8:30 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.

Date:Monday, November 10, 2025
Time:8:30 a.m. Eastern Time
Dial-in:1-844-425-9470
International Dial-in:201-298-0878
WebcastPRE Conference Call


An audio replay of the webcast will be available on the Company’s investor relations website at https://ir.prenetics.com/.

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8 — its flagship consumer brand co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka — now the fastest-growing supplement brand globally, reaching $100 million in annual recurring revenue within just 11 months of launch — the fastest growth ever recorded in the global history of the supplements industry, even outpacing today’s leading AI startups.

As the first consumer health company to establish a Bitcoin Treasury, Prenetics continues to pioneer at the intersection of health innovation and digital assets — purchasing 1 Bitcoin per day, now totaling 382 BTC as of November 4, 2025.

Investor Relations Contact:

investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com


FAQ

When will Prenetics (PRE) release Q3 2025 earnings?

Prenetics will release Q3 2025 results before market open on Monday, November 10, 2025.

What time is the Prenetics (PRE) Q3 2025 earnings call?

The inaugural earnings call is scheduled for 8:30 a.m. Eastern Time on November 10, 2025.

How can investors join the Prenetics (PRE) earnings call on November 10, 2025?

Dial 1-844-425-9470 for U.S. participants or 201-298-0878 for international callers; a live webcast is available on the company’s investor relations site.

Will Prenetics (PRE) provide a replay of the November 10, 2025 earnings call?

Yes. An audio replay of the webcast will be available on Prenetics’ investor relations website at https://ir.prenetics.com/.

Will there be a Q&A on the Prenetics (PRE) Q3 2025 conference call?

Yes. The call will conclude with a Q&A session with analysts following the management presentation.
Prenetics Ltd

NASDAQ:PRE

PRE Rankings

PRE Latest News

PRE Latest SEC Filings

PRE Stock Data

265.05M
14.55M
19.88%
12.67%
0.48%
Diagnostics & Research
Accident & Health Insurance
Link
Hong Kong
PEMBROKE